Steven Boyd insider trades: Avalo Therapeutics (AVTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
and 14 more companies
Open-market buys and sales
220 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 27, 2023 | AVTX | ↓ Sell | 3,683,542 | $0.59 | $2.2M | Indirect | Jun 28, 2023 (1d) |
| Mar 14, 2022 | AVTX | ↑ Buy | 226,000 | $0.67 | $152K | Indirect | Mar 14, 2022 (0d) |
| Mar 7, 2022 | AVTX | ↑ Buy | 510,000 | $0.67 | $344K | Indirect | Mar 7, 2022 (0d) |
| Feb 25, 2022 | AVTX | ↑ Buy | 140,000 | $0.80 | $112K | Indirect | Feb 28, 2022 (3d) |
| Feb 22, 2022 | AVTX | ↑ Buy | 288,000 | $0.80 | $232K | Indirect | Feb 22, 2022 (0d) |
| Jan 20, 2022 | AVTX | ↑ Buy | 312,000 | $0.88 | $274K | Indirect | Jan 20, 2022 (0d) |
| Jan 14, 2022 | AVTX | ↑ Buy | 455,000 | $1.00 | $453K | Indirect | Jan 14, 2022 (0d) |
| Jan 11, 2022 | AVTX | ↑ Buy | 645,000 | $1.00 | $643K | Indirect | Jan 11, 2022 (0d) |
| Sep 17, 2021 | AVTX | ↑ Buy | 5,700,000 | $2.20 | $12.6M | Indirect | Sep 17, 2021 (0d) |
| Aug 18, 2021 | CERC | ↑ Buy | 50,000 | $2.76 | $138K | Indirect | Aug 18, 2021 (0d) |
| Aug 6, 2021 | CERC | ↑ Buy | 150,000 | $2.72 | $409K | Indirect | Aug 6, 2021 (0d) |
| Aug 2, 2021 | EYEG | ↓ Sell | 260,963 | $2.48 | $647K | Indirect | Aug 3, 2021 (1d) |
| Jul 29, 2021 | EYEG | ↓ Sell | 3,153,138 | $4.61 | $14.5M | Indirect | Jul 29, 2021 (0d) |
| Jun 18, 2021 | RSLS | ↓ Sell | 2,303,469 | $6.18 | $14.2M | Direct | Jun 22, 2021 (4d) |
| May 18, 2021 | CERC | ↑ Buy | 180,000 | $2.18 | $392K | Direct | May 18, 2021 (0d) |
| Jan 8, 2021 | CERC | ↑ Buy | 2,500,000 | $2.60 | $6.5M | Direct | Jan 12, 2021 (4d) |
| Jan 6, 2021 | EYEG | ↑ Buy | 1,531,101 | $5.22 | $8.0M | Direct | Jan 8, 2021 (2d) |
| Dec 11, 2020 | AYTU | ↑ Buy | 1,333,334 | $6.00 | $8.0M | Direct | Dec 15, 2020 (4d) |
| Dec 4, 2020 | RSLS | ↑ Buy | 6,400 | $4.16 | $27K | Direct | Dec 4, 2020 (0d) |
| Dec 3, 2020 | CERC | ↑ Buy | 20,000 | $2.44 | $49K | Direct | Dec 7, 2020 (4d) |
| Nov 25, 2020 | CERC | ↑ Buy | 100,000 | $2.37 | $237K | Direct | Nov 25, 2020 (0d) |
| Nov 17, 2020 | RSLS | ↑ Buy | 977 | $4.21 | $4K | Direct | Nov 17, 2020 (0d) |
| Nov 10, 2020 | RSLS | ↑ Buy | 2,400 | $3.58 | $9K | Direct | Nov 12, 2020 (2d) |
| Nov 2, 2020 | RSLS | ↑ Buy | 3,100 | $3.56 | $11K | Direct | Nov 4, 2020 (2d) |
| Sep 30, 2020 | CTDH | ↓ Sell | 10,500 | $0.13 | $1K | Direct | Oct 1, 2020 (1d) |
| Sep 28, 2020 | CTDH | ↓ Sell | 43,223 | $0.13 | $6K | Direct | Sep 28, 2020 (0d) |
| Sep 23, 2020 | RSLS | ↑ Buy | 2,000 | $4.07 | $8K | Direct | Sep 25, 2020 (2d) |
| Sep 23, 2020 | CTDH | ↓ Sell | 167,000 | $0.15 | $25K | Direct | Sep 23, 2020 (0d) |
| Sep 22, 2020 | RSLS | ↑ Buy | 3,300 | $4.13 | $14K | Direct | Sep 22, 2020 (0d) |
| Sep 16, 2020 | CTDH | ↓ Sell | 337,084 | $0.16 | $55K | Direct | Sep 16, 2020 (0d) |
| Sep 16, 2020 | RSLS | ↑ Buy | 100 | $3.75 | $375 | Direct | Sep 16, 2020 (0d) |
| Sep 11, 2020 | CTDH | ↓ Sell | 1,003,070 | $0.18 | $176K | Direct | Sep 11, 2020 (0d) |
| Sep 8, 2020 | TENX | ↑ Buy | 32,000 | $1.42 | $46K | Direct | Sep 9, 2020 (1d) |
| Sep 8, 2020 | CTDH | ↓ Sell | 1,504,961 | $0.16 | $241K | Direct | Sep 8, 2020 (0d) |
| Sep 4, 2020 | CERC | ↑ Buy | 100,000 | $2.20 | $220K | Direct | Sep 9, 2020 (5d) |
| Sep 3, 2020 | TENX | ↑ Buy | 86,000 | $1.43 | $123K | Direct | Sep 3, 2020 (0d) |
| Aug 31, 2020 | TENX | ↑ Buy | 32,000 | $1.47 | $47K | Direct | Aug 31, 2020 (0d) |
| Aug 31, 2020 | CTDH | ↓ Sell | 165,263 | $0.11 | $19K | Direct | Aug 31, 2020 (0d) |
| Aug 26, 2020 | TENX | ↑ Buy | 34,903 | $1.51 | $53K | Direct | Aug 26, 2020 (0d) |
| Aug 21, 2020 | TENX | ↑ Buy | 311,481 | $1.48 | $460K | Direct | Aug 21, 2020 (0d) |
| Aug 20, 2020 | RSLS | ↑ Buy | 9,998 | $3.13 | $31K | Direct | Aug 20, 2020 (0d) |
| Jul 17, 2020 | RSLS | ↑ Buy | 4,500 | $3.00 | $14K | Direct | Jul 21, 2020 (4d) |
| Jun 29, 2020 | VXRT | ↓ Sell | 27,612,053 | $9.67 | $267.0M | Direct | Jun 30, 2020 (1d) |
| Jun 11, 2020 | CERC | ↑ Buy | 295,806 | $2.51 | $743K | Indirect | Jun 11, 2020 (0d) |
| Jun 9, 2020 | CERC | ↑ Buy | 1,753,680 | $2.50 | $4.4M | Direct | Jun 11, 2020 (2d) |
| Jun 3, 2020 | VXRT | ↓ Sell | 1,400,000 | $2.75 | $3.9M | Direct | Jun 3, 2020 (0d) |
| May 27, 2020 | VXRT | ↓ Sell | 200,000 | $2.61 | $522K | Direct | May 29, 2020 (2d) |
| May 22, 2020 | VXRT | ↓ Sell | 1,750,000 | $3.10 | $5.4M | Direct | May 22, 2020 (0d) |
| May 18, 2020 | VXRT | ↓ Sell | 1,943,308 | $2.92 | $5.7M | Direct | May 18, 2020 (0d) |
| May 13, 2020 | VXRT | ↓ Sell | 3,406,692 | $2.92 | $10.0M | Direct | May 13, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AVTX insiders
Open-market trades in the last 12 months
About Steven Boyd's insider trades
Steven Boyd is a 10% owner of Avalo Therapeutics (AVTX). Since May 8, 2017, Steven has reported 189 open-market purchases worth $115.1M and 31 sales worth $398.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (21 filings), option exercises (6 filings), conversions (5 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.